Concepedia

Melanie Paquette

MP

11

Publications

332

Citations

10

H-Index

2005

Active since

Affiliations

Oregon Health & Science University(Current)

University of Toronto

St. Michael's Hospital

The University of Texas Health Science Center at San Antonio

Arizona State University

Melanie Paquette is an author at Oregon Health & Science University specializing in medicine, neuropharmacology, and pharmacology.

Top concepts

Publications per year

2005–2022

11

Publications

11

Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats

Alex Martinez, Maria Grazia Morgese, Augusta Pisanu et al. · Neurobiology of Disease · 2014 · 61 citations · Full text

, , +8

Effect of Current Dietary Recommendations on Weight Loss and Cardiovascular Risk Factors

David J.A. Jenkins, Beatrice A. Boucher, Fredrick D. Ashbury et al. · Journal of the American College of Cardiology · 2017 · 50 citations · Full text

Anti‐dyskinetic mechanisms of amantadine and dextromethorphan in the 6‐OHDA rat model of Parkinson’s disease: role of NMDA vs. 5‐HT1A receptors

Melanie Paquette, Alex Martinez, Teresa Macheda et al. · European Journal of Neuroscience · 2012 · 45 citations · Full text

MK-801 inhibits l-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism

Melanie Paquette, Akari M. Anderson, Jason R. Lewis et al. · Neuropharmacology · 2010 · 33 citations · Full text

, , +6

The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism

Melanie Paquette, Katherine Foley, Elizabeth G. Brudney et al. · Psychopharmacology · 2009 · 31 citations · Full text

, , +9

Rows per page

1–5 of 11